drugset / Trial / NCT07227922
Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, single-center, open-label, single-dose trial. Sixteen participants are planned: 8 participants with moderate renal impairment and 8 matched control participants with normal renal function.
Timeline
- Start
- 2025-11-30
- Primary completion
- 2026-04-30
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | clofutriben | Small molecule | 12 mg | Oral |
Indications
No indication recorded.